Mechanism of Xianglian Pills in improving dyslipidemia in obese mice induced by high-fat diet based on network pharmacology and intestinal flora.
10.19540/j.cnki.cjcmm.20230818.401
- Author:
Ming-Wei PENG
1
;
Hua-Xin ZHAO
1
;
Fu SHU
2
;
Zhu CHEN
3
;
Lei SHI
4
;
Lyu-Jiang YUAN
1
;
Bao-Shun ZHANG
1
Author Information
1. College of Pharmaceutical Sciences, Southwest University Chongqing 400716, China.
2. College of Traditional Chinese Medicine, Chongqing Medical University Chongqing 402100, China.
3. Key Laboratory for Quality Monitoring of Anesthetic and Psychotropic Drugs of the National Drug Administration Chongqing 401121, China.
4. Affiliated Hospital of Liaoning University of Traditional Chinese Medicine Shenyang 110000, China.
- Publication Type:Journal Article
- Keywords:
Xianglian Pills;
brown fat;
dyslipidemia;
intestinal flora;
network pharmacology
- MeSH:
Mice;
Animals;
Mice, Obese;
Diet, High-Fat/adverse effects*;
Gastrointestinal Microbiome;
Network Pharmacology;
RNA, Ribosomal, 16S;
Diabetes Mellitus, Type 2/complications*;
Obesity/genetics*;
Body Weight;
Lipids;
Insulin;
Transcription Factors;
Dyslipidemias/genetics*;
Mice, Inbred C57BL;
Drugs, Chinese Herbal
- From:
China Journal of Chinese Materia Medica
2023;48(23):6442-6456
- CountryChina
- Language:Chinese
-
Abstract:
The present study aimed to investigate the effect of Xianglian Pills(XLP) on lipid metabolism in obese mice and explore the underlying mechanism based on network pharmacology and intestinal flora. Firstly, network pharmacology was used to predict the possible effect of XLP on obesity. Secondly, an obese mouse model induced by a high-fat diet was established to observe changes in mouse body weight, adiposity index, liver and adipose tissue pathology. Lipid profiles, liver and kidney function markers, insulin content, and the expression of recombinant uncoupling protein 1(UCP-1) and PR structural domain protein 16(PRDM16) were measured. The 16S rRNA gene sequencing technology was used to analyze the changes in the intestinal flora. Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analysis showed that XLP mainly played a role in improving obesity by regulating lipolysis, type 2 diabetes mellitus, and insulin resistance. The results of animal experiments showed that XLP significantly reduced body weight, adiposity, blood lipid levels, and serum insulin levels in obese mice, while enhancing the expression of UCP-1 and PRDM16 in adipose tissue without causing damage to the liver or kidneys. The 16S rRNA gene sequencing results showed that XLP decreased the Firmicutes/Bacteroidetes(F/B) ratio at the phylum level, increased the relative abundance of Akkermansia and Bacteroides at the family and genus levels, and reduced the abundance of Allobaculum. Therefore, XLP can effectively improve lipid metabolism disorders in high-fat diet-induced obese mice, and the mechanism is related to the improvement of brown adipose function, the browning of white fat, the accelerated lipid metabolism, and the improvement of intestinal flora. However, its effect on promoting the conversion of white adipose to brown adipose still needs to be further studied.
